Examining FDA’s Prescription Drug User Fee Program Video of Examining FDA’s Prescription Drug User Fee Program. Witnesses Mr. Jeff Allen President and CEO, Friends of Cancer Research Witness Statement Truth in Testimony and CV Ms. Kay Holcombe Senior Vice President of Science Policy, Biotechnology Industry Organization Witness Statement Truth in Testimony and CV Dr. Anne Pritchett Vice President of Policy and Research, Pharmaceutical Research and Manufacturers of America Witness Statement Truth in Testimony and CV Dr. Janet Woodcock Director, Food and Drug Administration, Center for Drug Evaluation and Research Witness Statement Truth in Testimony and CV Documents Hearing Notice Background Memo Preliminary Transcript Hearing Attendance Opening Statement – Health Subcommittee Chairman Michael C. Burgess Opening Statement – Full Committee Ranking Member Pallone Document for the Record – Rep. Burgess – NVCA Article Document for the Record – Rep. Burgess – RDLA Article Document for the Record – Rep. Burgess – Friends of Cancer Research Article Document for the Record – Rep. Burgess – Epilepsy Foundation Letter Related Items HEARING: #SubHealth to Continue User Fee Hearings, Examining PDUFA #SubHealth Looks at Reauthorization of Prescription Drug User Fee Act Subcommittees Health (115th Congress) Health hearing